Drug Type Cell therapy |
Synonyms Glial restricted progenitor cell therapy (Q Therapeutics) |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Sclerosis | Preclinical | US | 19 Sep 2024 | |
Spinal Cord Injuries | Preclinical | US | 19 Sep 2024 | |
Stroke | Preclinical | US | 19 Sep 2024 | |
Amyotrophic Lateral Sclerosis | Discovery | JP | - | |
Amyotrophic Lateral Sclerosis | Discovery | JP | - | |
Transverse Myelitis | Discovery | JP | - | |
Transverse Myelitis | Discovery | JP | - |